Page History
...
Team:
Jordyn Buchanan, Kaili Kan, Laureen Kapin, David Taylor, Drew Bagley, Waudo Siganga, Jamie Hedlund, Calvin Browne, Megan Richards, Gaongalelwe Mosweu
Observers: Zack Coleman
Staff: Brenda Brewer, Jean-Baptiste Deroulez, Pamela Smith, Margie Milam, Eleeza Agopian, Brian Aitchison, Antonietta Mangiacotti
Apologies: Jonathan Zuck, Dejan Djukic, Fabro Steibel
Agenda:
- Welcome, roll-call, SoI - Reach consensus on recommendations for:
a. Impact of Safeguards – Laureen
b. Benefits vs. Confusion to End Users – Megan
c. Registry Policies – Megan
Time permitting, also reach consensus on recommendations:
d. Preventing Delegations that would be confusing or harmful – Megan
e. Allowing specific communities to be served by a relevant TLD – Megan
f. Effectiveness of the Dispute Resolution Process in cases of Formal String Objection – Megan
g. Simplifying the process – Megan
- A.O.B.
Documents:
Recordings:
Chat Transcript: EN
Transcript: EN
Action Items:
- Jonathan to provide guidance on the priorities matrix - low, med, high, prerequisite, non-prerequisite
Notes:
VIII. IMPACT OF SAFEGUARDS (Continued)
Sensitive and Regulated Strings (p. 9) -
Rec. 1 (p. 9) - High priority, not a prerequisite for subsequent rounds - Consensus approved
Rec. 2 (p. 10) - add language about directing this to ICANN Board for resolution; add "respectively" after "sensitive health and financial information" - Consensus approved
Safeguards for Highly-Regulated Strings (p. 10-12)
All high priority, not a prerequisite
Rec. 1 - Consensus approved
Rec. 2 - Consensus approved
Rec. 3 - Consensus approved
Rec. 4 - Consensus approved
Rec. 5 - Consensus approved
Rec. 6 - Consensus approved
Special Safeguards (p. 13ff)
Low priority; not a prerequisite
Rec. - Consensus approved
Restricted Registration Policies (p. 14ff)
High priority, not a prerequisite for Rec. 1&2
Rec. 1 - Consensus approved
Rec. 2 - Consensus approved; look at subset of TLDs for which registration restrictions could possibly be appropriate
Rec. 3 - Consensus approved
Rec. 4 - Consensus approved (K.Kan conditional)
CONSUMER CHOICE POINT 12. BENEFITS vs. CONFUSION TO END-USERS
Med priority, prerequisite to next round(s)
Rec. -